Skip to main navigation
Skip to search
Skip to main content
Boise State University Home
Search content at Boise State University
Home
Profiles
Research units
Equipment
Projects
Research output
Datasets
Prizes
Activities
Press/Media
Doxorubicin Analogs Show Potent In Vitro Anti-Breast Cancer Activity
Cole Rice
, Phil Moon
, Ryan Carfi
,
Don Warner
,
Ken Cornell
Chemistry Department
Boise State University
Research output
:
Contribution to conference
›
Poster
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Doxorubicin Analogs Show Potent In Vitro Anti-Breast Cancer Activity'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Doxorubicin
100%
Doxorubicin Analogues
100%
Anti-breast Cancer Activity
100%
Breast Cancer
75%
Drug Use
25%
Cancer Mortality
25%
Cardiotoxicity
25%
Breast Cancer Treatment
25%
Treat Cancer
25%
Cardiac Damage
25%
Improved Activity
25%
Antiproliferative Activity
25%
Unwanted Side Effects
25%
Structural Substitution
25%
Breast Tumor
25%
Successful Treatment
25%
Cancer Causes
25%
Human Breast Cancer Cell Line
25%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Doxorubicin
100%
Side Effect
28%
Malignant Neoplasm
14%
Breast Tumor
14%
Antiinfective Agent
14%
Cancer Mortality
14%
Antiproliferative Activity
14%
Heart Injury
14%
Biochemistry, Genetics and Molecular Biology
Doxorubicin
100%
Cancer Cell
16%
Lifespan
16%
Cancer Mortality
16%
Low Drug Dose
16%
Antiproliferative Activity
16%